Thursday, June 20, 2024
Home Tags Clinical

Tag: clinical

Bio-Thera Solutions Announces Positive Phase 1 Clinical Data for BAT8006 (Folate…...

0
GUANGZHOU, China, Aug. 12, 2023 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative assets and biosimilars,...

Bio-Thera Solutions Announces Positive Phase 1 Clinical Data for BAT8006 (Folate…...

0
GUANGZHOU, China, Aug. 12, 2023 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative assets and biosimilars,...

Nexcella Announces NXC-201 Multiple Myeloma Clinical Data Abstract Accepted for …...

0
LOS ANGELES, July 25, 2023 (GLOBE NEWSWIRE) -- Nexcella, Inc. ("Nexcella", "Company", "We" or "Us"), today announced that updated NXC-201 relapsed/refractory...

Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progr… – Press...

0
Vivoryon Therapeutics N.V. Shares Clinical Development Update Highlighting Progress of N3pE-Amyloid-targeting Small Molecule Varoglutamstat in Alzheimer's DiseaseSmall molecule varoglutamstat, with potential for meaningful...

Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTO…...

0
Regulatory News: Sensorion (FR0012596468 – ALSEN) ALSEN a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and...

RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential...

0
The partnership focuses on combining novel antibody-drug conjugates RC88 and RC108 with a PD-1 inhibitor sintilimab for enhanced treatment outcomesYANTAI, China, July 9,...

Global Clinical Biomarkers Market Report 2023: Technological Advancements and Ri… –...

0
DUBLIN, July 3, 2023 /PRNewswire/ -- The "Clinical Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added...

New ENRICH-PLUS Study Builds on World’s First Positive Clinical Trial for...

0
NICO awards University of Maryland $200,000 for first-of-its-kind study combining MIPS with neuroprotectant for basal ganglia ICHINDIANAPOLIS, June 22, 2023 /PRNewswire/ -- Just two...

Intellia Therapeutics Announces New Positive Clinical Data from Phase 1 Study...

0
Extended Phase 1 data reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Across all patients...

Kura Oncology Presents Late-Breaking Clinical Data for Menin Inhibitor Ziftomeni… –...

0
– 35% CR rate (7/20) among patients with relapsed/refractory NPM1-mutant AML treated at 600 mg dose (RP2D) –– 33% (2/6) of patients with...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News